| __timestamp | Regeneron Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 1802274 |
| Thursday, January 1, 2015 | 838526000 | 2512761 |
| Friday, January 1, 2016 | 1177697000 | 2894488 |
| Sunday, January 1, 2017 | 1320433000 | 8096274 |
| Monday, January 1, 2018 | 1556200000 | 7985229 |
| Tuesday, January 1, 2019 | 1834800000 | 8994597 |
| Wednesday, January 1, 2020 | 1346000000 | 29772000 |
| Friday, January 1, 2021 | 1824900000 | 33907000 |
| Saturday, January 1, 2022 | 2115900000 | 26579000 |
| Sunday, January 1, 2023 | 2631300000 | 49868547 |
| Monday, January 1, 2024 | 2954400000 |
Data in motion
In the competitive world of biopharmaceuticals, understanding the financial dynamics of industry leaders is crucial. Regeneron Pharmaceuticals, Inc. and Verona Pharma plc, two prominent players, showcase contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Regeneron has seen a staggering 420% increase in SG&A expenses, peaking at $2.63 billion in 2023. This reflects their aggressive expansion and investment in marketing and administrative capabilities. In contrast, Verona Pharma's SG&A expenses, though significantly smaller, have grown by over 2,600%, reaching nearly $50 million in 2023. This surge indicates Verona's strategic push to enhance its market presence. These financial trajectories highlight the diverse strategies employed by these companies to navigate the ever-evolving pharmaceutical landscape.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Teva Pharmaceutical Industries Limited and Verona Pharma plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Catalent, Inc. and Verona Pharma plc
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Verona Pharma plc vs Travere Therapeutics, Inc.